BioSpace News Archive

The Rockefeller Foundation and leading global health partners announced a $100 million Precision Public Health initiative to empower community health systems and frontline health workers with the latest data science innovations, including more accurate and precise decision-making tools based on large, integrated datasets, predictive analytics, artificial intelligence, and machine learning.

OncoQuest Inc., a privately held, cancer immunotherapy company announced that a Notice of Allowance was received from the U.S. Patent and Trademark Office for patent protection of the schedule of administration of our monoclonal anti-CA-125 antibody, mAb-B43.13, now known as oregovomab, in a specific schedule in combination with carboplatin and paclitaxel in Stage III-IV ovarian cancer patients.